Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom macroglobulinemia. [PDF]
Tsakmaklis N +16 more
europepmc +1 more source
Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study. [PDF]
Autore F +26 more
europepmc +1 more source
Coexistence of Essential Thrombocythemia and Waldenström Macroglobulinemia: A Case Report. [PDF]
Wallace M +4 more
europepmc +1 more source
Extent of bone marrow infiltration predicts disease progression in asymptomatic Waldenström macroglobulinemia. [PDF]
Danesin N +14 more
europepmc +1 more source
Waldenström macroglobulinemia complicated with AL <i>λ</i> - type amyloid nephropathy: a case report and literature review. [PDF]
Ma Y, Li T, Li X.
europepmc +1 more source
Mesenteric Mass Causing Bowel Obstruction in Waldenström Macroglobulinemia. [PDF]
Magalhães E +4 more
europepmc +1 more source
A Rare Case of Waldenström Macroglobulinemia Presenting as Bilateral Bloody Pleural Effusion and Pancytopenia. [PDF]
Chen YQ, Wang H, Feng Q.
europepmc +1 more source
An Extremely Rare Cause of Protein-Losing Enteropathy: Waldenström Macroglobulinemia. [PDF]
Saab O +5 more
europepmc +1 more source
Zanubrutinib‑Induced Symmetrical Soft Tissue Forearm Swelling in a Patient With Waldenström Macroglobulinemia. [PDF]
Samperio VM, Ghonge A, Dasanu CA.
europepmc +1 more source
Prognostic value of <i>MYD88</i>/<i>CXCR4</i> mutation allele fraction in Waldenström macroglobulinemia using a multiplex ddPCR assay. [PDF]
Thanou E +18 more
europepmc +1 more source

